About Us

Our scientists and clinicians, with decades of cumulative knowledge and expertise, are dedicated to understanding cognition and behavior and improving health and well-being.

Our IT wizards get up every morning with a passion for innovation and impact.

Together, we work tirelessly to make the development of new brain-disease therapies more likely to succeed.

Our leadership team

Julie Stout

Julie C Stout PhD is a cognitive neuroscientist and clinical neuropsychologist with more than 25 years of experience in academic research in progressive neurodegenerative diseases in the US and Australia. She has consulted for numerous clinical trials and served on several advisory boards for a range of sponsors working on Huntington’s disease, Alzheimer’s disease, Attention Deficit Hyperactivity Disorder and more. She co-founded Stout Neuropsych in 2014, and Zindametrix in 2017 to facilitate the implementation of evidence-based cognitive assessments in clinical trials.

Kian Davoodi
Chief Information Officer

Kian is an innovative and forward-thinking Chief Information Officer over 15 years of robust experience in data science, IT strategy, and leadership. Proven expertise in steering the technological direction of companies, overseeing the development of comprehensive IT solutions, and leading digital transformation initiatives. Adept in aligning technology initiatives with business goals, driving efficiency, and fostering a culture of continuous improvement. Committed to leveraging extensive knowledge in data management, analytics, and machine learning, along with a strong foundation in software development, to deliver strategic value and maintain competitive edge in the market.

Merima Murathodzic
Training and certifications

Merima is a clinical neuropsychologist with nine years of experience in clinical trials, including study coordination, and examiner training. She has overseen training and certification of hundreds of examiners worldwide.

Martin Stone
Finance and Accounting

Martin is an experienced financial officer, with six years of experience in the clinical trial sector and >25 years of experience in medical science.

Planning a clinical trial for Alzheimer's, Parkinson's, Huntington or other neurodegenerative or brain conditions?

Contact us to learn how we can help